Clorox Divests Aplicare Skin Unit To Medline Industries
Zacks Investment Research | Aug 22, 2017 09:10PM ET
The Clorox Company (NYSE:CLX) announced the sale of its Aplicare skin antisepsis business to Medline Industries. This was done in accordance with the former’s 2020 Strategy, which is aimed at boosting growth for the improvement of categories and overall market share. However, the financial terms of the deal that concluded on Aug 21, remained under covers.
Notably, Aplicare business that was part of Clorox’s Professional Products business, contributed nearly $46 million in fiscal 2017, reflecting not more than 1% of the company’s overall sales as well as insignificant earnings.
In fact, the Illinois-based Medline Industries, which is the leading privately-held maker and distributor of medical supplies, is likely to enhance the performance of the Aplicare business with its solid capabilities and explorations. Also, it will cater top-tier health care products and services to its customers.
With the sale of its Aplicare skin unit, Clorox does not free itself from the responsibility of focusing strategically on its Professional Products business and the company will continue to stop the spread of infection as well as kill pathogens.
Throwing light upon Clorox’s 2020 Strategy, we note that the strategy is aimed at achieving certain long-term aspirations, including growing net sales by 3-5%, increasing EBIT margin by 25-50 basis points and generating free cash flow of 10-12% of sales, all on a yearly basis.
Meanwhile, Clorox seems to be well on track with the execution of the strategy, which is meant to be achieved through key accelerators like investment in brands; development of eCommerce; technological advancements; enhancement of growth culture and focus on the 3Ds – desire, decision and delight.
Evidently, the 2020 Strategy coupled with other factors drove the company’s fiscal 2017 performance. Going forward, Clorox is likely to deliver another year of solid earnings and sales growth in fiscal 2018 aided by these factors. Concurrently, management has also stated that it will issue an updated outlook for fiscal 2018 on Nov 1, when it reports fiscal first-quarter results.
In fact, shares of Clorox have outpaced the broader Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.